Pharmigene, Inc. (TPEX:7595)
Taiwan · Delayed Price · Currency is TWD 11.45
0.00 (0.00%)
Jul 11, 2025, 9:09 AM CST
Pharmigene Market Cap
Pharmigene has a market cap or net worth of 577.82 million as of July 17, 2025. Its market cap has decreased by -41.58% in one year.
Market Cap
577.82M
Enterprise Value
1.04B
Revenue
116.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.45
Market Cap Chart
Since December 22, 2020, Pharmigene's market cap has decreased from 1.08B to 577.82M, a decrease of -46.61%. That is a compound annual growth rate of -12.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 577.82M | -19.65% |
| Dec 31, 2024 | 719.13M | -31.16% |
| Dec 29, 2023 | 1.04B | 21.08% |
| Dec 30, 2022 | 862.78M | -8.53% |
| Dec 30, 2021 | 943.19M | -13.20% |
| Dec 31, 2020 | 1.09B | 0.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 188.45B |
| PharmaEssentia | 182.63B |
| Bora Pharmaceuticals Co., LTD. | 85.85B |
| Lotus Pharmaceutical | 56.80B |
| Oneness Biotech | 29.27B |
| Polaris Group | 28.81B |
| Center Laboratories | 26.28B |
| Lumosa Therapeutics | 24.48B |